105 related articles for article (PubMed ID: 14676118)
1. Concurrent carboplatin and paclitaxel definitive radiation therapy for locally advanced head and neck cancer.
Han J; Zakeri K; Raab G; Hesse J; Shamseddine A; Chen L; Yu Y; Kang JJ; McBride SM; Riaz N; Tsai CJ; Gelblum D; Sherman EJ; Wong RJ; Michel L; Lee NY
Head Neck; 2023 Sep; 45(9):2207-2216. PubMed ID: 37439286
[TBL] [Abstract][Full Text] [Related]
2. p16INK4a Status and Response to Induction Low-Dose Fractionated Radiation in Advanced Head and Neck Cancer.
Silver NL; Arnold SM; Gleason JF; Kudrimoti M; Brill Y; Dressler EV; Valentino J
Ann Otol Rhinol Laryngol; 2015 Sep; 124(9):714-20. PubMed ID: 25810339
[TBL] [Abstract][Full Text] [Related]
3. Treatment outcomes after definitive radio(chemo)therapy for 17 lacrimal sac squamous cell carcinoma.
Song X; He H; Zhu Y; Wang S; Wang J; Wang W; Li Y
Br J Radiol; 2020 Nov; 93(1115):20190633. PubMed ID: 32970475
[TBL] [Abstract][Full Text] [Related]
4. Rebuttal to comment on "Concurrent carboplatin and paclitaxel definitive radiation therapy for locally advanced head and neck cancer".
Han JE; Zakeri K; Michel L; Sherman EJ; Lee NY
Head Neck; 2024 Jan; 46(1):230-231. PubMed ID: 37881148
[No Abstract] [Full Text] [Related]
5. Comment on "Concurrent carboplatin and paclitaxel definitive radiation therapy for locally advanced head and neck cancer".
Li X; Liu L
Head Neck; 2024 Jan; 46(1):228-229. PubMed ID: 37880929
[No Abstract] [Full Text] [Related]
6. Quality of Life Analysis of HPV-Positive Oropharyngeal Cancer Patients in a Randomized Trial of Reduced-Dose Versus Standard Chemoradiotherapy: 5-Year Follow-Up.
Takahashi M; Hwang M; Misiukiewicz K; Gupta V; Miles BA; Bakst R; Genden E; Selkridge I; Botzler J; Virani V; Moshier E; Bonomi MR; Posner MR
Front Oncol; 2022; 12():859992. PubMed ID: 35463348
[TBL] [Abstract][Full Text] [Related]
7. A phase I trial adding poly(ADP-ribose) polymerase inhibitor veliparib to induction carboplatin-paclitaxel in patients with head and neck squamous cell carcinoma: Alliance A091101.
Jelinek MJ; Foster NR; Zoroufy AJ; Schwartz GK; Munster PN; Seiwert TY; de Souza JA; Vokes EE
Oral Oncol; 2021 Mar; 114():105171. PubMed ID: 33513474
[TBL] [Abstract][Full Text] [Related]
8. Comparing high-dose cisplatin with cisplatin-based combination chemotherapy in definitive concurrent chemoradiation setting for locally advanced head and neck squamous cell carcinoma (LAHNSCC).
Furqan M; Snyders TP; Saqlain MU; Mott SL; Laux D; Snow A; Anderson CM; Watkins JM; Clamon GH
Cancer Med; 2019 Jun; 8(6):2730-2739. PubMed ID: 30968604
[TBL] [Abstract][Full Text] [Related]
9. Using low-dose radiation to potentiate the effect of induction chemotherapy in head and neck cancer: Results of a prospective phase 2 trial.
Arnold SM; Kudrimoti M; Dressler EV; Gleason JF; Silver NL; Regine WF; Valentino J
Adv Radiat Oncol; 2016; 1(4):252-259. PubMed ID: 28740895
[TBL] [Abstract][Full Text] [Related]
10. Cisplatin-based chemotherapy versus cetuximab in concurrent chemoradiotherapy for locally advanced head and neck cancer treatment.
Hu MH; Wang LW; Lu HJ; Chu PY; Tai SK; Lee TL; Chen MH; Yang MH; Chang PM
Biomed Res Int; 2014; 2014():904341. PubMed ID: 25110705
[TBL] [Abstract][Full Text] [Related]
11. DNA repair biomarkers XPF and phospho-MAPKAP kinase 2 correlate with clinical outcome in advanced head and neck cancer.
Seiwert TY; Wang X; Heitmann J; Villegas-Bergazzi V; Sprott K; Finn S; O'Regan E; Farrow AD; Weichselbaum RR; Lingen MW; Cohen EE; Stenson K; Weaver DT; Vokes EE
PLoS One; 2014; 9(7):e102112. PubMed ID: 25019640
[TBL] [Abstract][Full Text] [Related]
12. Survival and selected outcomes of older adults with locally advanced head/neck cancer treated with chemoradiation therapy.
Maggiore RJ; Curran EK; Witt ME; Haraf DJ; Vokes EE; Cohen EE
J Geriatr Oncol; 2013 Oct; 4(4):327-33. PubMed ID: 24472475
[TBL] [Abstract][Full Text] [Related]
13. Study of functional infrared imaging for early detection of mucositis in locally advanced head and neck cancer treated with chemoradiotherapy.
Cohen EE; Ahmed O; Kocherginsky M; Shustakova G; Kistner-Griffin E; Salama JK; Yefremenko V; Novosad V
Oral Oncol; 2013 Oct; 49(10):1025-31. PubMed ID: 23988569
[TBL] [Abstract][Full Text] [Related]
14. Induction chemotherapy with cetuximab, carboplatin and paclitaxel for the treatment of locally advanced squamous cell carcinoma of the head and neck.
Bauman J; Langer C; Quon H; Algazy K; Lin A; Desai A; Mutale F; Weiss J
Exp Ther Med; 2013 Apr; 5(4):1247-1253. PubMed ID: 23599744
[TBL] [Abstract][Full Text] [Related]
15. Alteration in TWIST expression: possible role in paclitaxel-induced apoptosis in human laryngeal carcinoma Hep-2 cell line.
Yu L; Li HZ; Lu SM; Liu WW; Li JF; Wang HB; Xu W
Croat Med J; 2009 Dec; 50(6):536-42. PubMed ID: 20017221
[TBL] [Abstract][Full Text] [Related]
16. Evaluating and reporting dysphagia in trials of chemoirradiation for head-and-neck cancer.
Gluck I; Feng FY; Lyden T; Haxer M; Worden F; Chepeha DB; Eisbruch A
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):727-33. PubMed ID: 19783380
[TBL] [Abstract][Full Text] [Related]
17. Advances in molecular diagnostics and therapeutics in head and neck cancer.
Chai RL; Grandis JR
Curr Treat Options Oncol; 2006 Jan; 7(1):3-11. PubMed ID: 16343364
[TBL] [Abstract][Full Text] [Related]
18. State-of-the-art management of locally advanced head and neck cancer.
Seiwert TY; Cohen EE
Br J Cancer; 2005 Apr; 92(8):1341-8. PubMed ID: 15846296
[TBL] [Abstract][Full Text] [Related]
19. Induction chemotherapy followed by concomitant TFHX chemoradiotherapy with reduced dose radiation in advanced head and neck cancer.
Haraf DJ; Rosen FR; Stenson K; Argiris A; Mittal BB; Witt ME; Brockstein BE; List MA; Portugal L; Pelzer H; Weichselbaum RR; Vokes EE
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5936-43. PubMed ID: 14676118
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
